Radiation plus L-TC for soft tissue sarcoma before surgery
Part of Cancer clinical trials.
This trial tests whether adding a drug called L-TC (liposomal transcrocetin) to standard radiation therapy before surgery can help treat soft tissue sarcoma of the arm or leg. It is for people whose cancer is grade 2 or 3 (moderate to high grade) and has not spread to other parts of the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a soft tissue sarcoma in an arm or leg that is grade 2 or 3 (not low grade).
- Your doctor has planned to give you radiation therapy and surgery to remove the tumor.
- You have an MRI scan of the tumor area that was done before any biopsy.
- You are able to have an MRI scan (for example, no metal implants that are not safe for MRI).
- You are generally well enough to be up and about at least half of the day (performance status 0-2) and expected to live at least 6 more months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a shorter course of radiation before surgery is effective for soft tissue sarcomas in certain locations. It aims to make treatment more convenient while maintaining good results.
This trial tests a new type of radiation called spatially fractionated radiation therapy (SFRT) given before surgery for large soft tissue sarcomas in the arm, leg, or trunk. The goal is to see if it helps shrink the tumor and improve treatment outcomes.
This trial tests a new approach for high-risk soft tissue sarcoma of the arm, leg, or trunk. Before surgery, you would receive chemotherapy combined with local hyperthermia (a treatment that gently heats the tumor area) to see if this can improve outcomes.
This trial tests a shorter course of radiation given before surgery for soft tissue sarcoma in the arms, legs, or trunk wall. It aims to see if this approach works well long-term and may help you keep your limb.
This Phase 2 trial tests whether giving radiation before surgery, along with anlotinib and penpulimab, can improve treatment for localized soft tissue sarcoma. It may help shrink or control the tumor before conservative surgery.
This trial tests whether adding immunotherapy drugs (anlotinib and penpulimab) to radiation before surgery can help treat soft tissue sarcoma—a type of cancer in muscles, fat, or connective tissue. The goal is to shrink the tumor and improve surgical outcomes.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.